arrow
H

Houtan Noushmehr

Henry Ford Health System
H指数:82
被引数:9.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

METHYLATION-BASED CLASSIFIER IMPROVES MENINGIOMA PROGNOSTICATION

甲基化基分类器提高了脑膜瘤预后评估

2025-11-010
OAAI
INTEGRATIVE MODELING OF EPIGENETIC AND MRI FEATURES IN MENINGIOMA PROGNOSTICATION

表观遗传和MRI特征在脑膜瘤预后判断中的整合建模

2025-11-010
OAAI
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon

弥漫性半球神经胶质瘤,H3 G34-mutant疾病发展,DNA修复,微环境和治疗方法的综述

2025-08-140
OAAI
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium

脑肿瘤液体活检方法中的前分析变量和检测物:RANO Group和Brain Liquid Biopsy Consortium的综述与建议

2025-08-010
PRE
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets

基于蛋白质组学的干性评分测量癌性去分化并能够识别可药物靶点

2025-04-170
OAAI
Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment

发育状态、p53状态和干扰素信号对胶质母细胞瘤细胞对辐射和替莫唑胺治疗的反应的影响

2025-02-070
OA
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

IDH突变型胶质瘤的肿瘤分级、年龄、强化和切除程度的生物学意义: 在IDH抑制剂时代,它们应该如何为治疗决策提供信息?

2024-06-244
OAAI
Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas
2023-09-1314
OAAI
Targeted sequencing of cancer-related genes reveals a recurrent TOP2A variant which affects DNA binding and coincides with global transcriptional changes in glioblastoma
2023-06-205
PRE
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
2023-06-011
OAAI